Seeking Nominations for Stefanie's Champions Caregivers

October 05, 2012

COLUMBUS, Ohio – The 14th annual Stefanie's Champions Awards is seeking nominations for caregivers who are helping improve the lives of cancer patients. Five Champions will be honored during the annual awards luncheon to be held Wednesday, April 10, 2013 at the Archie M. Griffin Grand Ballroom at The Ohio State University's Ohio Union.

Each Champion must exemplify the qualities and values important to Stefanie Spielman, her husband, Chris Spielman, and their children including:

  • Putting families first
  • Demonstrating acts of kindness and dedication to a cancer patient
  • Elevating a patient's battle with cancer above all other personal needs

Cancer survivors or parents/guardians of cancer survivors younger than 18, can nominate a Champion by visiting www.spielmanfund.com. Nominations are due by Jan. 1, 2013.
Stefanie Spielman, whose battle with cancer ended in November 2009, gave the first Champion award to her husband, a former football standout at The Ohio State University and the National Football League.

Chris Spielman put his professional football career on hold to care for her when she was first treated for breast cancer in 1998 at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Stefanie's Champions, now entering its 14th year, continues to honor those whose commitment and strength were influential in the lives of cancer survivors.

Proceeds from the Stefanie's Champions awards luncheon benefit the Stefanie Spielman Patient Assistance Fund and the Stefanie Spielman Fund for Breast Cancer Research at The James. Since 1999, more than $10 million has been raised to support these funds.

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 41 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers and one of only seven centers funded by the NCI to conduct both phase I and phase II clinical trials. The NCI recently rated Ohio State's cancer program as "exceptional," the highest rating given by NCI survey teams. As the cancer program's 210-bed adult patient-care component, The James is a "Top Hospital" as named by the Leapfrog Group and one of the top cancer hospitals in the nation as ranked by U.S. News & World Report.

###

Contact: Alexis Shaw, Wexner Medical Center Public Affairs and Media Relations, 614-293-3737 or Alexis.Shaw2@osumc.edu

Contact Media Staff

Amanda Harper

Director of Media Relations


614-685-5420 (direct)


614-293-3737 (main)


Amanda.Harper2@osumc.edu


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.

 

If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).

Latest News

New Clinical Trial Aims to Reprogram Cells to Attack a Specific Relapsed Blood Cancer

An upcoming clinical trial at The James aims to reprogram a patient’s immune cells to attack a specific relapsed blood cancer, called multiple myeloma. The idea is to “super-charge” the patient’s immune...

Read More

NCCN Publishes New Guidelines for Smoking Cessation, Effort Led by Ohio State Oncologist

To meet the needs of patients who are smokers at the time of a cancer diagnosis, the National Comprehensive Cancer Network has published smoking cessation guidelines. Ohio State's Peter Shields, MD...

Read More

Molecules in Prostate Tumors Might Predict Whether RT Can Help Prevent Recurrence

A new study has identified a group of molecules in prostate-cancer cells that doctors might one day use to distinguish which patients should be treated with radiation therapy if rising PSA levels...

Read More